Related Experiment Video
Updated: Mar 29, 2026

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
Published on: June 7, 2019
Imipramine administration induces changes in the phosphorylation of FAK and PYK2 and modulates signaling pathways
Teresa Zalewska1, Adam Bielawski2, Luiza Stanaszek1
1NeuroRepair Department, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Background:
Antidepressants can modify neuronal functioning by affecting many levels of signal transduction pathways that are involved in neuroplasticity. We investigated whether the phosphorylation status of focal adhesion kinase (FAK/PTK2) and its homolog, PYK2/PTK2B, and their complex with the downstream effectors (Src kinase, p130Cas, and paxillin) are affected by administration of the antidepressant drug, imipramine. The treatment influence on the levels of ERK1/2 kinases and their phosphorylated forms (pERK1/2) or the Gαq, Gα11 and Gα12 proteins were also assessed.
Methods:
Rats were injected with imipramine (10 mg/kg, twice daily) for 21 days. The levels of proteins investigated in their prefrontal cortices were measured by Western blotting.
Results:
Imipramine induced contrasting changes in the phosphorylation of FAK and PYK2 at Tyr397 and Tyr402, respectively. The decreased FAK phosphorylation and increased PYK2 phosphorylation were reflected by changes in the levels of their complex with Src and p130Cas, which was observed predominantly after chronic imipramine treatment. Similarly only chronic imipramine decreased the Gαq expression while Gα11 and Gα12 proteins were untouched. Acute and chronic treatment with imipramine elevated ERK1 and ERK2 total protein levels, whereas only the pERK1 was significantly affected by the drug.
Conclusion:
The enhanced activation of PYK2 observed here could function as compensation for FAK inhibition.
General Significance:
These data demonstrate that treatment with imipramine, which is a routine in counteracting depressive disorders, enhances the phosphorylation of PYK2, a non-receptor kinase instrumental in promoting synaptic plasticity. This effect documents as yet not considered target in the mechanism of imipramine action.
Insights
Imipramine treatment alters focal adhesion kinase (FAK) and PYK2 phosphorylation, enhancing PYK2 activation. This suggests a novel mechanism for imipramine
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Antidepressants modulate neuronal signaling pathways crucial for neuroplasticity.
- Focal adhesion kinase (FAK/PTK2) and its homolog PYK2/PTK2B are key regulators of neuronal function.
- Investigating imipramine's effects on FAK, PYK2, and associated signaling proteins is essential for understanding its mechanism of action.
Purpose of the Study:
- To determine how imipramine affects the phosphorylation status of FAK and PYK2.
- To analyze the impact of imipramine on the complex formation of FAK/PYK2 with downstream effectors like Src kinase, p130Cas, and paxillin.
- To assess imipramine's influence on ERK1/2 kinases and G-protein subunits (Gαq, Gα11, Gα12).
Main Methods:
- Rats received imipramine (10 mg/kg, twice daily) for 21 days.
- Protein levels in prefrontal cortices were quantified using Western blotting.
Main Results:
- Imipramine induced differential phosphorylation of FAK (decreased at Tyr397) and PYK2 (increased at Tyr402).
- Chronic imipramine treatment altered the complex formation of FAK/PYK2 with Src and p130Cas.
- Imipramine increased total ERK1/2 levels and specifically phosphorylated ERK1, while decreasing Gαq expression.
Conclusions:
- Enhanced PYK2 activation may compensate for imipramine-induced FAK inhibition.
- Imipramine promotes PYK2 phosphorylation, a critical kinase for synaptic plasticity.
- This study identifies a previously unrecognized target of imipramine's action in treating depressive disorders.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways
IP3/DAG Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

